| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |